EGR1 regulates cellular metabolism and survival in endocrine resistant breast cancer

About 70% of all breast cancers are estrogen receptor alpha positive (ER+; ESR1). Many are treated with antiestrogens. Unfortunately, de novo and acquired resistance to antiestrogens is common but the underlying mechanisms remain unclear. Since growth of cancer cells is dependent on adequate energy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Shajahan-Haq, Ayesha N., Boca, Simina M., Jin, Lu, Bhuvaneshwar, Krithika, Gusev, Yuriy, Cheema, Amrita K., Demas, Diane D., Raghavan, Kristopher S., Michalek, Ryan, Madhavan, Subha, Clarke, Robert
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5722529/
https://ncbi.nlm.nih.gov/pubmed/29228577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18292
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares